The latest extraordinary price hike (after Valeant and Martin Shkreli’s Turing) is the 400% price increase in 8 years of EpiPen from Pharma company Mylan.
In the same time, it’s CEO pay has increased a whopping 671%.
These facts are conveniently left out of a National Review article. We get the usual rant against the public sector and politicians, stuff like “Politicians are parasites, bums, they don’t produce anything,” etc.
One of the tasks of the public sector is to safeguard the public from abusive pricing by companies..